Detection of circulating tumor DNA in patients with osteosarcoma

Identification and quantification of somatic alterations in plasma-derived, circulating tumor DNA (ctDNA) is gaining traction as a non-invasive and cost effective method of disease monitoring in cancer patients, particularly to evaluate response to treatment and monitor for disease recurrence. To ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Barris, David M., Weiner, Shoshana B., Dubin, Robert A., Fremed, Michael, Zhang, Xusheng, Piperdi, Sajida, Zhang, Wendong, Maqbool, Shahina, Gill, Jonathan, Roth, Michael, Hoang, Bang, Geller, David, Gorlick, Richard, Weiser, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849166/
https://www.ncbi.nlm.nih.gov/pubmed/29560102
http://dx.doi.org/10.18632/oncotarget.24268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849166/
https://www.ncbi.nlm.nih.gov/pubmed/29560102
http://dx.doi.org/10.18632/oncotarget.24268

Ejemplares similares